HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

CUSIP: 427746102

Q2 2017 13F Holders as of 30 Jun 2017

Holder snapshot 7 signals
Share change
+3,406,465
Put/Call ratio
4.3%
SEC-reported price per share
$13.85
Number of holders
102
Value change
+$47,548,351
Number of buys
61
Open additional details 1 more signal available
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
182,615,507

Security key

427746102

Report period

Q2 2017

Institutions

102

Top holders

10

Ownership snapshot

Top reported holders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
TANG CAPITAL MANAGEMENT LLC
Comparable rows
15/15
Latest evidence
31 Mar 2017
13F Lead comparable stake: 4.7% Showing 1-6 of 15 holder rows.

Quick read

TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 4.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
TANG CAPITAL MANAGEMENT LLC 4.7%
FRANKLIN RESOURCES INC 4.6%
FMR LLC 4.4%
JANUS HENDERSON INVESTORS US LLC 3%
Broadfin Capital, LLC 2.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
4.7%
$129,824,000
8,654,914 shares
31 Mar 2017
FRANKLIN RESOURCES INC
13F
Company
13F
4.6%
$126,802,000
8,453,095 shares
31 Mar 2017
FMR LLC
13F
Company
13F
4.4%
$120,464,000
8,030,880 shares
31 Mar 2017
JANUS HENDERSON INVESTORS US LLC
13F
Company
13F
3%
$82,524,000
5,501,755 shares
31 Mar 2017
Broadfin Capital, LLC
13F
Company
13F
2.7%
$74,211,000
4,947,403 shares
31 Mar 2017
PFM Health Sciences, LP
13F
Company
13F
2.2%
$58,991,000
3,932,730 shares
31 Mar 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
102
Shares
69,617,065
Rows available
102
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders
98
Q2 2017 holders
102
Holder diff
4
Investor Q1 2017 Shares Q2 2017 Shares Share Diff Share Chg % Q1 2017 value Q2 2017 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .